Guardant Health, Inc.
505 Penobscot Dr
Redwood City, CA 94063-4737
Biotech and Pharmaceutical
Guardant Health, headquartered in Redwood City, Calif., is focused on developing breakthrough diagnostics that can transform cancer from a silent killer into a manageable disease. Guardant Health was founded in 2012 by a team of serial entrepreneurs with expertise in next-generation sequencing, single-cell genomics and cancer diagnostics. The company has raised $100 million in funding from leading venture capital firms and its first product, Guardant360, came to market in 2014. The team is committed to positively and significantly impacting patient health through technology that addresses long-standing unmet needs in oncology.
Guardant Health has a blood based, NGS, 68 gene panel to help oncologists and drug developers improve therapy decision support and accelerate drug development. We cover SNVs in all 68 genes, amplifications in 16, including MET, PDGFRA, PIK3CA, fusions in 4 and indels in EGFR (with MET and ERBB2 to be added shortly).